OCATA THERAPEUTICS

Ocata Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of Regenerative Ophthalmology therapeutics. Ocata’s most advanced products are in clinical trials for the treatment of Stargardt’s macular degeneration, dry age-related macular degeneration, and myopic macular degeneration. Ocata’s intellectual property portfolio includes pluripotent stem cell platforms – hESC and induced pluripotent stem cell (iPSC) – and other cell therapy research programs.

#People #Financial #Website #More

OCATA THERAPEUTICS

Social Links:

Facebook

Linkedin

Twitter

Industry:

Biotechnology Health Care Therapeutics

Founded:

1994-01-01

Address:

Marlborough, Massachusetts, United States

Country:

United States

Website Url:

http://www.ocata.com

Total Employee:

11+

Status:

Closed

Contact:

(508) 756-1212

Email Addresses:

[email protected]

Total Funding:

42.78 M USD

Technology used in webpage:

SPF Amazon Amazon Ohio Region Comcast Amazon California Region NameBright

Current Advisors List

not_available_image

Constance Cepko Scientific Advisory Board Member @ Ocata Therapeutics
Advisor

robert-langer_image

Robert Langer Chairman of the Scientific Advisory Board @ Ocata Therapeutics
Advisor
2014-09-01

not_available_image

Joseph Vacanti Scientific Advisory Board Member @ Ocata Therapeutics
Advisor

michael-t-heffernan_image

Michael T. Heffernan Board of Directors (Chairman) @ Ocata Therapeutics
Board_member

not_available_image

Michael Longaker Scientific Advisory Board Member @ Ocata Therapeutics
Advisor

gregory-d-perry_image

Gregory D. Perry Board of Directors @ Ocata Therapeutics
Board_member

brian-levy_image

Brian Levy Board of Directors Member @ Ocata Therapeutics
Board_member
2015-08-29

Current Employees Featured

dr-robert-lanza_image

Dr. Robert Lanza
Dr. Robert Lanza Chief Scientific Officer @ Ocata Therapeutics
Chief Scientific Officer

not_available_image

Kathy Singh
Kathy Singh Director Program Management @ Ocata Therapeutics
Director Program Management
2005-01-01

eddy-anglade_image

Eddy Anglade
Eddy Anglade CMO @ Ocata Therapeutics
CMO

gary-rabin_image

Gary Rabin
Gary Rabin Chairman of the Board & CEO @ Ocata Therapeutics
Chairman of the Board & CEO
2007-01-01

Founder

paul-wotton_image

Paul Wotton

Stock Details

Company's stock symbol is NASDAQ:OCAT

Investors List

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Post-IPO Debt - Ocata Therapeutics

lincoln-park-capital-fund_image

Lincoln Park Capital Fund

Lincoln Park Capital Fund investment in Post-IPO Equity - Ocata Therapeutics

Official Site Inspections

http://www.ocata.com

Host Informations
Whois Informations

Loading ...

More informations about "Ocata Therapeutics" on Search Engine